ATE75778T1 - Immunosuppressionsfaktor. - Google Patents

Immunosuppressionsfaktor.

Info

Publication number
ATE75778T1
ATE75778T1 AT85810114T AT85810114T ATE75778T1 AT E75778 T1 ATE75778 T1 AT E75778T1 AT 85810114 T AT85810114 T AT 85810114T AT 85810114 T AT85810114 T AT 85810114T AT E75778 T1 ATE75778 T1 AT E75778T1
Authority
AT
Austria
Prior art keywords
factor
immunosupression
interleukin
exhibits
activity
Prior art date
Application number
AT85810114T
Other languages
English (en)
Inventor
Adriano Section Of Cli Fontana
University Hospital Medicine
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP84810140A external-priority patent/EP0155433A1/de
Priority claimed from GB848429679A external-priority patent/GB8429679D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE75778T1 publication Critical patent/ATE75778T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Glass Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT85810114T 1984-03-23 1985-03-15 Immunosuppressionsfaktor. ATE75778T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP84810140A EP0155433A1 (de) 1984-03-23 1984-03-23 Immunsuppressionsfaktor
GB848429679A GB8429679D0 (en) 1984-11-23 1984-11-23 Immunosuppressant factor

Publications (1)

Publication Number Publication Date
ATE75778T1 true ATE75778T1 (de) 1992-05-15

Family

ID=26095665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85810114T ATE75778T1 (de) 1984-03-23 1985-03-15 Immunosuppressionsfaktor.

Country Status (12)

Country Link
EP (1) EP0159289B1 (de)
JP (1) JPH0680080B2 (de)
AT (1) ATE75778T1 (de)
AU (1) AU587973B2 (de)
CA (1) CA1341401C (de)
DE (1) DE3585968D1 (de)
DK (1) DK171600B1 (de)
IE (1) IE58821B1 (de)
IL (1) IL74680A (de)
NZ (1) NZ211525A (de)
WO (1) WO1985004421A1 (de)
ZA (1) ZA852194B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172052B1 (da) * 1984-12-21 1997-09-29 Otsuka Pharma Co Ltd Antitumor-aktivt stof, fremgangsmåde til dets fremstilling, lægemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme transformet med en sådan vektor
US6107465A (en) * 1984-12-21 2000-08-22 Otsuka Pharmaceutical Co., Ltd. IL-1β and derivatives thereof and drugs
US5342614A (en) * 1984-12-21 1994-08-30 Otsuka Pharmaceutical Co., Ltd. Method of treating arthritus or inflammation with IL-1β or derivatives thereof
US5284763A (en) * 1985-03-22 1994-02-08 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US6586394B1 (en) 1985-04-19 2003-07-01 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitor
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
JPS63126897A (ja) * 1986-05-02 1988-05-30 Yoshitomi Pharmaceut Ind Ltd 免疫抑制因子
AU612617B2 (en) * 1986-11-17 1991-07-18 Sandoz Ag Production and use of a novel t-cell suppressor factor
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
US5250414A (en) * 1988-11-04 1993-10-05 Erziehungsdirektion Of The Canton Zurich Diagnostic methods using neurite growth regulatory factors
CA1341050C (en) * 1988-11-04 2000-07-11 Martin E. Schwab Neurite growth regulatory factors
WO1990005191A1 (en) * 1988-11-04 1990-05-17 Erziehungsdirektion Of The Canton Zurich Neurite growth regulatory factors
WO1998046640A2 (en) * 1997-04-15 1998-10-22 Coulter International Corp. Methods and compositions for inducing immunosuppression
EP2333064A1 (de) 1998-11-06 2011-06-15 University of Zürich Nukleotid- und Proteinsequenzen von Nogo-Genen und darauf basierende Verfahren
EP1165101A2 (de) * 1999-03-24 2002-01-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Induzierung einer antigen-spezifischen nichtantwort mit überständen von glioblastomkulturen
US7101543B2 (en) 2000-03-31 2006-09-05 Novarx Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells

Also Published As

Publication number Publication date
EP0159289B1 (de) 1992-05-06
WO1985004421A1 (en) 1985-10-10
DK539285A (da) 1985-11-21
DK539285D0 (da) 1985-11-21
IE850732L (en) 1985-09-23
ZA852194B (en) 1986-11-26
AU4157685A (en) 1985-11-01
JPS61501514A (ja) 1986-07-24
IL74680A0 (en) 1985-06-30
EP0159289A1 (de) 1985-10-23
CA1341401C (en) 2002-11-26
IL74680A (en) 1988-11-30
DK171600B1 (da) 1997-02-17
IE58821B1 (en) 1993-11-17
DE3585968D1 (de) 1992-06-11
AU587973B2 (en) 1989-09-07
NZ211525A (en) 1991-06-25
JPH0680080B2 (ja) 1994-10-12

Similar Documents

Publication Publication Date Title
DE3869184D1 (de) Festelektrolyt-brennstoffzelle und zusammenbau.
NO167240C (no) Feste med flere frihetsgrader.
ATE75778T1 (de) Immunosuppressionsfaktor.
DE3576941D1 (de) Sicherheitsgurtsystem.
DE3582861D1 (de) Brennstoffzellensystem.
DE3581578D1 (de) Antikoerper, herstellung und verwendung.
NO893484L (no) Brenselcelle.
DE3888640D1 (de) Stromregler.
DE3675039D1 (de) Polsterungsteil.
DE68922501T2 (de) Enzymelektrode.
ATE73338T1 (de) Biologisch wirksame kopolymere.
ES2017712B3 (es) Regulador de fuel multi-adaptativo.
DE3677810D1 (de) Brennstoffzelle.
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
FI883527A (fi) Elektrolytisk cell.
FI891201A0 (fi) Elektrokemisk cell.
DE69102115D1 (de) Bipolare Batterie und Zusammenbau-Methode.
NL192550B (nl) Brandstofcel.
DE3576017D1 (de) Monolitisch integrierte leistungsendstufe.
FI850441L (fi) Elektrolytisk cell.
DE3667230D1 (de) Verstaerkeranordnung.
DE3574652D1 (de) Verstaerkeranordnung.
DE3671685D1 (de) Verstaerkeranordnung.
DE68911865T2 (de) Stromverstärker.
NO851398L (no) Taakeleggingslegeme.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time